| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 5 2579-2586, Copyright © 1995 by American Association of Immunologists
ARTICLES |
DA Bullough, MJ Magill, GS Firestein and KM Mullane
Department of Cardiovascular Pharmacology, Gensia, Inc., San Diego, CA 92121, USA.
Inhibition of neutrophil-myocyte adhesion and adhesion-dependent myocyte injury by adenosine was evaluated using isolated TNF-alpha- activated canine cells. Adenosine inhibited adhesion of activated neutrophils to cardiac myocytes with an IC50 of 11 +/- 4 nM. Inhibition of neutrophil adhesion (92 +/-3% by 100 nM adenosine) led to inhibition of myocyte injury (by 90 +/- 6%, as assessed by dye exclusion). Inhibition of cell adhesion by adenosine was blocked by the A2 antagonist, 1,3-dimethyl-1-propylxanthine, but not by the A1 antagonist, 8-cyclopentyl-1,3-dipropylxanthine. Moreover, the A2 agonist, CGS21680 (2-[4-(2-carboxymethyl)phenethylamino]-5'-N- ethylcarboxamido adenosine), but not the A1 agonist, N6- cyclopentyladenosine, mimicked adenosine in preventing cell adhesion. These observations implicate the A2 receptor in the mechanism of inhibition of cell adhesion. pretreatment and washing of neutrophils, but not cardiac myocytes, with adenosine or CGS21680 led to inhibition of adhesion, suggesting that the neutrophil A2 receptor is the target of adenosine's action. In contrast, inhibition of cell adhesion by adenosine was poteniated by 8-cyclopentyl-1,3-dipropylxanthine (IC50 = 4 +/- 1 nM) and attenuated by N6-cyclopentyladenosine, suggesting that occupancy of A1 receptors can conversely increase cell adhesion. Neutrophil-myocyte adhesion was inhibited by acadesine (IC50 = 12 +/- 2 microM) also via an adenosine-dependent mechanism because it was blocked by 1,3-dimethyl-1-propylxanthine or adenosine deaminase, an enzyme that degrades any adenosine that is formed. Acadesine-induced inhibition if cell adhesion (83 +/- 4% by 100 microM) resulted in inhibition of myocyte injury (by 76 +/- 6%). Other adenosine-regulating agents, including the acadesine analogue, GP531 (5-amino-1 beta-D-(5- benzylamino-5-deoxyribofuranosyl) imidazole-4-carboxamide), and inhibitors of adenosine transport and intracellular metabolism also inhibited cell adhesion. These results indicate that exogenous or endogenous adenosine can inhibit neutrophil-myocyte adhesion and injury in cells activated with TNF-alpha by an A2-mediated mechanism. Although the predominant activity of adenosine is to attenuate cell adhesion, stimulation of A1 receptors has the opposite effect, i.e., to augment adhesive interactions.
This article has been cited by other articles:
|
|
 |
|
  G. E. Garcia, L. D. Truong, P. Li, P. Zhang, J. Du, J.-F. Chen, and L. Feng Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis FASEB J, February 1, 2008; 22(2): 445 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Gaskin, K. Kamada, M. Yusof, and R. J. Korthuis 5'-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H326 - H332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Awad, L. Huang, H. Ye, E. T. A. Duong, W. K. Bolton, J. Linden, and M. D. Okusa Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F828 - F837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Platts, J. Linden, and B. R. Duling Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2360 - H2367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Fiser, C. G. Tribble, A. K. Kaza, S. M. Long, J. A. Kern, D. C. Cassada, J. Linden, J. Rieger, V. E. Laubach, A. Matisoff, et al. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Thibault, C. Burelout, D. Harbour, P. Borgeat, P. H. Naccache, and S. G. Bourgoin Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes J. Leukoc. Biol., February 1, 2002; 71(2): 367 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Okusa A2A adenosine receptor: a novel therapeutic target in renal disease Am J Physiol Renal Physiol, January 1, 2002; 282(1): F10 - F18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Cassada, J. J. Gangemi, J. M. Rieger, J. Linden, A. K. Kaza, S. M. Long, I. L. Kron, C. G. Tribble, and J. A. Kern Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord Ann. Thorac. Surg., October 1, 2001; 72(4): 1245 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mubagwa and W. Flameng Adenosine, adenosine receptors and myocardial protection: An updated overview Cardiovasc Res, October 1, 2001; 52(1): 25 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Okusa, J. Linden, L. Huang, J. M. Rieger, T. L. Macdonald, and L. P. Huynh A2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion Am J Physiol Renal Physiol, November 1, 2000; 279(5): F809 - F818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Okusa, J. Linden, T. Macdonald, and L. Huang Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney Am J Physiol Renal Physiol, September 1, 1999; 277(3): F404 - F412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chello, P. Mastroroberto, E. Malta, F. Cirillo, and V. Celi Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery Ann. Thorac. Surg., May 1, 1999; 67(5): 1277 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Smits, M. McVey, B. F. Cox, M. H. Perrone, and K. L. Clark Cardioprotective Effects of the Novel Adenosine A1/A2 Receptor Agonist AMP 579 in a Porcine Model of Myocardial Infarction J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 611 - 618. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. R. Meldrum Tumor necrosis factor in the heart Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R577 - R595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bauer, M. G. Bouma, I. Herrmann, F. A. J. M. Van Den Wildenberg, G. S. Firestein, I. Marzi, and W. A. Buurman Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotension Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1297 - G1303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Olah and M. E. Olah Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS. ANALYSIS OF CHIMERIC A1/A2a ADENOSINE RECEPTORS J. Biol. Chem., January 3, 1997; 272(1): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Jordan, Z.-Q. Zhao, H. Sato, S. Taft, and J. Vinten-Johansen Adenosine A2 Receptor Activation Attenuates Reperfusion Injury by Inhibiting Neutrophil Accumulation, Superoxide Generation and Coronary Endothelial Adherence J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 301 - 309. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
